Triplet–triplet annihilation (TTA) mechanism utilizing the conversion of low triplet energy excitons to generate singlet excitons has been successfully employed in realizing highly efficient fluorescent organic light‐emitting diodes (OLEDs). Herein, new anthracene‐based TTA molecules (TPNACN and TPBACN) are developed as deep‐blue emitters for high‐efficiency non‐doped TTA‐OLEDs. Their structural, physical, and photophysical properties are experimentally and theoretically investigated. These compounds in solid‐state exhibit different photophysical properties due to a discrepancy in the molecular packing. Particularly, in the crystal of TPNACN, anthracene moieties are arranged with dimeric π–π stacking, and the material shows a strong excimer emission in the deep‐blue region with ΦPL close to the ideal theoretical value. The non‐doped TTA‐OLED based on TPNACN attains a high maximum external quantum efficiency of 7.89% (6.63 cd A−1) with a low turn‐on voltage of 2.6 V, and displays deep‐blue emission with CIE coordinates of (0.146, 0.101). These results prove that a separated dimeric π‐stacked molecular alignment of anthracene enhances not only the fluorescence efficiency in the solid state but also the ratio of singlet exciton harvested by the TTA process in the device, bringing about excellent device electroluminescent properties. This can be a new tactic to designing new emissive materials for efficient OLED devices.
Benzoin condensation of aromatic aldehydes catalysed by N,N -dimethylbenzimidazolium iodide and NaOH was performed either in ionic liquid or water or in the absence of solvent. Reusability of the catalyst mixture in all cases was demonstrated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.